Form 4: CoreCivic Director Emkes Receives Stock Grant

Sentiment:

SEC Form 4 Filing


Director Mark A. Emkes of CoreCivic, Inc. reports acquisition of 8,098 shares of common stock through restricted stock units.

Summary

  • Mark A. Emkes, a director at CoreCivic, Inc., filed a Form 4 on February 20, 2025, reporting a transaction.
  • On February 19, 2025, Emkes acquired 8,098 shares of CoreCivic common stock through the grant of restricted stock units (RSUs).
  • These RSUs vest in full on the first anniversary of the grant date, contingent upon continued service with CoreCivic.
  • Following the reported transaction, Emkes beneficially owns 157,362 shares of CoreCivic common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.

Positives

  • The grant of restricted stock units to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's success.

Future Outlook

The restricted stock units vest in full on the first anniversary of the grant date, subject to continued service with the Issuer through such vesting date.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders.

Stakeholder Impact

  • The stock grant aligns the director's interests with those of the shareholders.

Key Dates

DateDescription
02/19/2025Date of the transaction: Grant of restricted stock units.
02/20/2025Date of Form 4 filing.

Keywords

CoreCivic, Director, Emkes, Stock, RSU, CXW, Form 4, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.